(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 11.26% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.07%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.73%.
Evolent Health's revenue in 2024 is $2,353,868,000.On average, 5 Wall Street analysts forecast EVH's revenue for 2024 to be $299,790,549,962, with the lowest EVH revenue forecast at $297,891,760,654, and the highest EVH revenue forecast at $301,900,290,018. On average, 5 Wall Street analysts forecast EVH's revenue for 2025 to be $340,828,029,227, with the lowest EVH revenue forecast at $324,589,705,865, and the highest EVH revenue forecast at $355,610,164,463.
In 2026, EVH is forecast to generate $375,365,108,886 in revenue, with the lowest revenue forecast at $352,487,767,787 and the highest revenue forecast at $393,775,503,947.